Epiendo Pharmaceuticals

This study tested a new drug called EP395 in 49 healthy adults to see if it could reduce inflammation in the lungs. Participants inhaled a substance that causes temporary airway inflammation, and those who received EP395 were expected to have less inflammation than those who rece…

This study tested an experimental drug called EP395 in 40 healthy adults. Researchers used a safe, temporary lung inflammation model (inhaled endotoxin) to see how the drug affects immune markers and to check its safety. The goal was to gather early information, not to treat a di…

This early-stage study tested the safety and tolerability of a new drug called EP395 in 78 healthy adults aged 18 to 65. Participants received single or multiple doses of the drug in capsule form. The goal was to find a safe dose range for future research.

This study looked at how a new medicine called EP395, being developed for COPD, interacts with other common drugs. Healthy adults aged 18 to 55 took part to see how EP395 levels change when taken with verapamil, and how EP395 affects midazolam and digoxin. The goal was to gather …